Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 501–600 of 1,001
Development of a High-Throughput Candida albicans Biofilm Chip
Srinivasan, A., Uppuluri, P., Lopez-Ribot, J., & Ramasubramanian, A. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019036 · Cited by 47
El-Azizi, M., Farag, N. S., & Khardori, N. M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0083-3 · Cited by 50
Tunçbilek, M., & Altanlar, N. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200500180 · Cited by 50
Schaffer, T., Müller, S., Flogerzi, B., Seibold-Schmid, B., Schoepfer, A. M., & Seibold, F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20228 · Cited by 50
Cohen, Y., Shafinoori, S., Tucci, V., & Rubin, L. G. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000095195.60494.ba · Cited by 50
Özkan, S. A., Kaynak, F., Kalkancı, A., Abbasoğlu, U., & Kuştımur, S. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000300019 · Cited by 50
A genome-wide transcriptional analysis of morphology determination in Candida albicans
Carlisle, P. L., & Kadosh, D. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-01-0065 · Cited by 49
Pfaller, M. A., Carvalhaes, C. G., Smith, C. J., Diekema, D. J., & Castanheira, M. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115016 · Cited by 49
Self-citationGlittenberg, M. T., Silas, S., MacCallum, D. M., Gow, N. A. R., & Ligoxygakis, P. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006619 · Cited by 49
Determination of Antifungal Susceptibility Patterns Among the Clinical Isolates of Candida Species
Zomorodian, K., Rahimi, M., Pakshir, K., Motamedi, M., Ghiasi, M., & Rezashah, H. (2011) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.91059 · Cited by 49
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
Childers, D. S., Mundodi, V., Banerjee, M., & Kadosh, D. (2014) · Molecular Microbiology · doi:10.1111/mmi.12576 · Cited by 49
Finkelstein, R., Fusman, R., Oren, I., Kassis, I., & Hashman, N. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.118406 · Cited by 49
Synthesis and antifungal activity of some substituted phenothiazines and related compounds
Sarmiento, G. P., Vitale, R. G., Afeltra, J., Moltrasio, G. Y., & Moglioni, A. G. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.10.019 · Cited by 49
Gang-sheng, W. A. N. G., Deng, J., Ma, Y., Min, S. H. I., & Li, B. (2012) · 中医杂志:英文版 · doi:10.1016/s0254-6272(12)60026-0 · Cited by 49
Antimicrobial and free radical scavenging activities of five palestinian medicinal plants
Qabaha, K. (2013) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v10i4.17 · Cited by 49
Cheng, S., Clancy, C. J., Zhang, Z., Hao, B., Wang, W., Iczkowski, K. A., Pfaller, M. A., & Nguyen, M. H. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00805.x · Cited by 46
Self-citationMolecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
Oprea, S. F., Zaidi, N., Donabedian, S. M., Balasubramaniam, M., Hershberger, E., & Zervos, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh138 · Cited by 49
Multiple‐species candidemia in patients with cancer
Boktour, M. R., Kontoyiannis, D. P., Hanna, H. A., Hachem, R. Y., Girgawy, E., Bodey, G. P., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20573 · Cited by 49
Blood Gene Expression Signatures Predict Invasive Candidiasis
Zaas, A. K., Aziz, H., Lucas, J., Perfect, J. R., & Ginsburg, G. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000715 · Cited by 48
Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., & Baddour, L. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02188-06 · Cited by 48
“faecalis isolates in the United States (5, 8).”
BackgroundComparison of vancomycin-resistant enterococci isolates from human, poultry and pigs in Korea
Seo, K. S., Lim, J. Y., Yoo, H. S., Bae, W. K., & Park, Y. H. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2004.11.017 · Cited by 48
Fisher, B. T., Zaoutis, T., Park, J. R., Bleakley, M., Englund, J. A., Kane, C., Arceci, R. J., Guinan, E. C., Smith, F. O., Luan, X., et al. (2012) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pis044 · Cited by 48
Chiarini, A., Palmeri, A., Amato, T., Immordino, R., Distefano, S. A., & Giammanco, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01014-08 · Cited by 48
Control of Candida albicans morphology and pathogenicity by post-transcriptional mechanisms
Kadosh, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2294-y · Cited by 48
Correlation between phospholipase of Candida albicans and resistance to fluconazole
Su, Y., & Li, C. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02024.x · Cited by 48
Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata
Barchiesi, F., Spreghini, E., Tomassetti, S., Arzeni, D., Giannini, D., & Scalise, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4989-4992.2005 · Cited by 43
Hanberger, H., Erlandsson, M., BURMAN, L. G., Cars, O., Gill, H., Lindgren, S., Nilsson, L. E., Olsson-Liljequist, B., Walther, S., & The Icu-strama Study Group (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017429 · Cited by 48
Conserved Fungal Genes as Potential Targets for Broad-Spectrum Antifungal Drug Discovery
Liu, M., Healy, M. D., Dougherty, B. A., Esposito, K. M., Maurice, T. C., Mazzucco, C. E., Bruccoleri, R. E., Davison, D. B., Frosco, M., Barrett, J. F., et al. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.4.638-649.2006 · Cited by 48
The Host’s Reply to Candida Biofilm
Nett, J. (2016) · Pathogens · doi:10.3390/pathogens5010033 · Cited by 47
Chamilos, G., Nobile, C. J., Bruno, V. M., Lewis, R. E., Mitchell, A. P., & Kontoyiannis, D. P. (2009) · The Journal of Infectious Diseases · doi:10.1086/599363 · Cited by 47
Caspofungin Acetate for Treatment of Invasive Fungal Infections
Pacetti, S. A., & Gelone, S. P. (2003) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2003)037<0090:caftoi>2.0.co;2 · Cited by 47
Harris, M. R., & Coote, P. J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.021 · Cited by 47
Antifungal treatment in pediatric patients
Zaoutis, T. E., Benjamin, D. K., & Steinbach, W. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.06.005 · Cited by 47
Shareck, J., Nantel, A., & Belhumeur, P. (2011) · Eukaryotic Cell · doi:10.1128/ec.00305-10 · Cited by 47
Characterization of Ers, a PrfA-like regulator ofEnterococcus faecalis
Giárd, J.-C., Riboulet-Bisson, E., Verneuil, N., Sanguinetti, M., Auffray, Y., & Hartke, A. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2005.00049.x · Cited by 47
Clinical Trials of Antifungal Prophylaxis among Patients Undergoing Surgery
Calandra, T., & Marchetti, O. (2004) · Clinical Infectious Diseases · doi:10.1086/421955 · Cited by 47
Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients
Hadley, S., Lee, W. W., Ruthazer, R., & Nasraway, S. A. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00023 · Cited by 46
Weig, M., Haynes, K., Rogers, T. R., Kurzai, O., Frosch, M., & Mühlschlegel, F. A. (2001) · Microbiology · doi:10.1099/00221287-147-8-2007 · Cited by 46
UsingCaenorhabditis elegansfor antimicrobial drug discovery
Desalermos, A. P., Muhammed, M., Glavis‐Bloom, J., & Mylonakis, E. E. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.573781 · Cited by 46
Finnish Leukemia Group, Syrjälä, H., Ohtonen, P. P., Kinnunen, U., Räty, R., Elonen, E., Nousiainen, T., Jantunen, E., Remes, K., Itälä‐Remes, M., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0984-1 · Cited by 46
Rosseti, I. B., da Rocha, J. B. T., & Costa, M. S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.08.001 · Cited by 46
Hsueh, P.-R., Teng, L.-J., Yang, P.-C., Ho, S.-W., & Luh, K.-T. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469570 · Cited by 41
The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans
Ferwerda, G., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Romani, L. R., & Kullberg, B. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.082 · Cited by 46
Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography
Bleeker‐Rovers, C. P., Warris, A., Drenth, J. P. H., Corstens, F. H. M., Oyen, W. J. G., & Kullberg, B.-J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01155.x · Cited by 46
Antifungal prophylaxis with azole derivatives
Castagnola, E., Machetti, M., Bucci, B., & Viscoli, C. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00847.x · Cited by 46
High-Throughput Nano-Biofilm Microarray for Antifungal Drug Discovery
Srinivasan, A., Leung, K. P., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · mBio · doi:10.1128/mbio.00331-13 · Cited by 41
Minces, L. R., Ho, K. S., Veldkamp, P. J., & Clancy, C. J. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903161531 · Cited by 45
Epidemiology of Bloodstream Infections in the First Year After Pediatric Lung Transplantation
Danziger‐Isakov, L. A., Sweet, S. C., DelaMorena, M., Huddleston, C. B., Mendeloff, E. N., & DeBaun, M. R. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000157089.42020.41 · Cited by 45
Midkiff, J., Borochoff-Porte, N., White, D., & Johnson, D. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025395 · Cited by 44
Banerjee, D., Lelandais, G., Shukla, S., Mukhopadhyay, G., Jacq, C., Devaux, F., & Prasad, R. (2008) · Eukaryotic Cell · doi:10.1128/ec.00256-07 · Cited by 44
Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy
Sarıhan, S., Ercan, İ., Saran, A., Çetintaş, S., Akalın, H., & Engin, K. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.11.001 · Cited by 44
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.08.001 · Cited by 44
Microbiological Characteristics of Medically Important Trichosporon Species
Li, H., Du, H., Liu, W., Wan, Z., & Li, R. (2005) · Mycopathologia · doi:10.1007/s11046-005-0112-4 · Cited by 44
Laín, A., Moragues, M. D., García‐Ruiz, J. C., Mendoza, J., Camacho, A., del Palacio, A., & Pontón, J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-06 · Cited by 44
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors
Boo, T. W., O'Reilly, B., O'Leary, J., & Cryan, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01134.x · Cited by 37
Asghar, A. H. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3348 · Cited by 44
Raman, S. B., Nguyen, M. H., Zhang, Z., Cheng, S., Jia, H. Y., Weisner, N., Iczkowski, K., & Clancy, C. J. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05121.x · Cited by 43
Filipiak, W., Sponring, A., Filipiak, A., Baur, M., Ager, C., Wiesenhofer, H., Margesin, R., Nagl, M., Troppmair, J., & Amann, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-44-462613-4.00023-4 · Cited by 43
Sarıgüzel, F. M., Berk, E., Koç, A. N., Sav, H., & Demir, G. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.5359 · Cited by 43
Orasch, C., Weisser, M., Mertz, D., Conen, A., Heim, D. A., Christen, S. E., Gratwohl, A. A., Battegay, M., Widmer, A. F., & Flückiger, U. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.187 · Cited by 43
Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria
Rattanaumpawan, P., Ussavasodhi, P., Kiratisin, P., & Aswapokee, N. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-167 · Cited by 43
Iwaya, A., Nakagawa, S., Iwakura, N., Taneike, I., Kurihara, M., Kuwano, T., Gondaira, F., Endo, M., Hatakeyama, K., & Yamamoto, T. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.05.041 · Cited by 43
Buu, L.-M., & Chen, Y. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-22 · Cited by 43
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 43
Terlecká, J., du Cros, P., Morrissey, C. O., & Spelman, D. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01307.x · Cited by 43
Jones, R. N., Jenkins, S. G., Hoban, D. J., Pfaller, M. A., & Ramphal, R. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00152-7 · Cited by 43
Self-citationBarchiesi, F., Spreghini, E., Maracci, M., Fothergill, A. W., Baldassarri, I., Rinaldi, M. G., & Scalise, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3317-3322.2004 · Cited by 43
No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011
Meyer, E., Geffers, C., Gastmeier, P., & Schwab, F. (2013) · Eurosurveillance · doi:10.2807/ese.18.24.20505-en · Cited by 42
Carreño, A., Rodríguez, L. M., Páez‐Hernández, D., Martin‐Trasanco, R., Zúñiga, C., Oyarzún, D. P., Gacitúa, M. A., Schott, E., Arratia‐Pérez, R., & Fuentes, J. A. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00312 · Cited by 42
The Role of HVAC Design and Windows on the Indoor Airflow Pattern and ACH
Pirouz, B., Palermo, S. A., Naghib, S. N., Mazzeo, D., Turco, M., & Piro, P. (2021) · Sustainability · doi:10.3390/su13147931 · Cited by 42
DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections
Yoo, S. M., Choi, J. Y., Yun, J. K., Choi, J., Shin, S. Y., Lee, K., Kim, J. M., & Lee, S. Y. (2009) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2009.09.003 · Cited by 42
Bulacio, L., Paz, M., Ramadán, S., Ramos, L., Pairoba, C. F., Sortino, M. A., Escovich, L., & López, C. C. O. (2012) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2012.08.002 · Cited by 42
Polymicrobial candidaemia revealed by peripheral blood smear and chromogenic medium
Yera, H., Poulain, D., Lefebvre, A., Camus, D., & Sendid, B. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.9340 · Cited by 42
Resolution of Discrepant Results for Candida Species Identification by Using DNA Probes
Coignard, C., Hurst, S. F., Benjamin, L. E., Brandt, M. E., Warnock, D. W., & Morrison, C. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.858-861.2004 · Cited by 41
Zhang, X.-B., Yu, S.-J., Yu, J.-X., Gong, Y.-L., Feng, W., & Sun, F.-J. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.510 · Cited by 41
In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
Sarkar, S., Uppuluri, P., Pierce, C. G., & Lopez-Ribot, J. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01745-13 · Cited by 41
Kanafani, Z. A., Kourany, W. M., Fowler, V. G., Levine, D. P., Vigliani, G. A., Campion, M., Katz, D. E., Corey, G. R., & Boucher, H. W. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0808-3 · Cited by 41
Das, S., Brown, T. M., Kellar, K. L., Holloway, B. P., & Morrison, C. J. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2005.00031.x · Cited by 41
Vasileiou, E., Apsemidou, A., Vyzantiadis, T., & Tragiannidis, A. (2018) · Current Medical Mycology · doi:10.18502/cmm.4.3.173 · Cited by 41
Friendly fungi: symbiosis with commensal Candida albicans
Shao, T., Haslam, D. B., Bennett, R. J., & Way, S. S. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.07.003 · Cited by 41
Lipiński, T., Wu, X., Sadowska, J., Kreiter, E., Yasui, Y., Cheriaparambil, S., Rennie, R. P., & Bundle, D. R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.010 · Cited by 41
Gómez‐Raja, J., & Davis, D. A. (2012) · Eukaryotic Cell · doi:10.1128/ec.05211-11 · Cited by 41
Nace, H., Horn, D., & Neofytos, D. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.010 · Cited by 41
Petraitienė, R., Petraitis, V., Kelaher, A. M., Sarafandi, A. A., Mickiene, D., Groll, A. H., Sein, T., Bacher, J., & Walsh, T. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2084-2092.2005 · Cited by 41
Schülin, T., & Voss, A. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00053.x · Cited by 41
Barrier Activity in Candida albicans Mediates Pheromone Degradation and Promotes Mating
Schaefer, D., Côte, P., Whiteway, M., & Bennett, R. J. (2007) · Eukaryotic Cell · doi:10.1128/ec.00090-07 · Cited by 40
“Unlike S. cerevisiae, which is commonly found growing in the soil or on the surfaces of fruit, C. albicans is a natural commensal of humans and an opportunistic pathogen, with the potential to cause both mucosal and systemic infections ( 13 ).”
BackgroundInvasive candidiasis and candidaemia in neonates and children: update on current guidelines
Tragiannidis, A., Tsoulas, C., & Groll, A. H. (2014) · Mycoses · doi:10.1111/myc.12268 · Cited by 40
Şimşek, M. (2019) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_362_18 · Cited by 40
Aziz, M. S., Patel, A. L., Losavio, J., Iyengar, A., Berven, M., Schloemer, N. J., Jakubowicz, A., Mathai, T., & Mcauley, J. B. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181bf8eb1 · Cited by 40
Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
Lode, H. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01220.x · Cited by 40
Bahna, P., Hanna, H. A., Dvorak, T. L., Vaporciyan, A. J., Chambers, M. S., & RAAD, I. I. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.02.002 · Cited by 40
Relationship between neighborhood poverty rate and bloodstream infections in the critically ill*
Mendu, M. L., Zager, S., Gibbons, F. K., & Christopher, K. B. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318241e51e · Cited by 39
The diverse roles of autophagy in medically important fungi
Palmer, G. E., Askew, D. S., & Williamson, P. R. (2008) · Autophagy · doi:10.4161/auto.7075 · Cited by 39
A one-year survey of candidemia in Belgium in 2002
SWINNE, D., WATELLE, M., SUETENS, C., MERTENS, K., FONTEYNE, P.-A., & NOLARD, N. (2004) · Epidemiology and Infection · doi:10.1017/s095026880400295x · Cited by 39
Pais, P., Califórnia, R., Galocha, M., Viana, R., Ola, M., Cavalheiro, M., Takahashi‐Nakaguchi, A., Chibana, H., Butler, G., & Teixeira, M. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-20 · Cited by 39
Han, X., Zhu, X., Hong, Z., Wei, L., Ren, Y., Wan, F., Zhu, S., Peng, H., Guo, L., Rao, L., et al. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00763 · Cited by 39
Baddley, J. W., Smith, A. M., Moser, S. A., & Pappas, P. G. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00214-0 · Cited by 39
Quantitation of mecA Transcription in Oxacillin-Resistant Staphylococcus aureus Clinical Isolates
Rosato, A. E., Craig, W. A., & Archer, G. L. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.11.3446-3452.2003 · Cited by 39
A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia
Pasqualotto, A. C., Nedel, W. L., Machado, T., & Severo, L. C. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.012 · Cited by 39
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.